Brent Standridge, Chief Operating Officer at ARATANA THERAPEUTICS, INC. (PETX), sold 10,000 shares at $4.56 ($46K) on 2018-06-25, disclosed to the SEC on 2018-06-27.
Scheduled sale ($46k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.